window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Patient Centricity

  • Clinical & Regulatory,Digital & Data,Opinion & Events

    Nine ladies dancing: uMotif – patient-centric trials and AI take centre stage in 2026

    As part of Discover Pharma’s 12 days of Christmas series, [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events

    uMotif: patient-centricity took flight again in 2025 like four calling birds

    In 2025, patient-centricity, just like the four calling birds soared [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    Saphnelo self-administration Phase 3 trial meets primary endpoint in systemic lupus erythematosus

    AstraZeneca has reported positive interim results from the Phase 3 [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events,Pharmaceuticals and therapeutics

    Almirall study shows psoriasis treatment improves skin and psychological well-being

    Almirall has presented new two-year results from its POSITIVE study [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Neurogen biomarking virtual care ecosystem cuts time to Alzheimer’s intervention by 4.5 years

    New data presented at the Alzheimer’s Association International Conference 2025 [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    Phesi CEO warns of looming Phase 3 trial failures as sponsors overlook real-world data and overcrowd sites

    New analysis reveals billions risked on overly complex trials that [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    Flexibility and precision: How Phastar is driving innovation in clinical trials

    As the pharmaceutical industry marks World Clinical Trials Day 2025, [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Patient priorities must shape trial design, says One2Treat lead

    To mark Clinical Trials Day, Discover Pharma speaks with Tom [...]

    May 5, 2026
  • Opinion & Events

    Global patient access gets boost with myTomorrows and Scout Clinical collaboration

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • OrganaBio to manufacture RxMP haemostatic therapy RMP-402
    Categories: Advanced Therapies, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
  • Symeres expands spray drying capacity at New Jersey site to support poorly soluble small molecules
    Categories: Biotech & Pharma Business, Drug Delivery & Formulation, Drug Discovery & Development
  • Axplora consolidates UDCA manufacturing at Vizag site to strengthen integrated global supply and support future growth
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top